CompoAtlas

千維健膠囊食品

千維健膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
CAYENNE FRUITCAYENNE FRUITNot identified
DESICCATED LIVER POWDERDESICCATED LIVER POWDERNot identified
SOYBEAN EXTRACTSOYBEAN EXTRACTNot identified
DL-ALPHA TOCOPHERYL ACETATEDL-ALPHA TOCOPHERYL ACETATEVitamine E
PHYLLANTHUS URINARIA L. EXTRACTPHYLLANTHUS URINARIA L. EXTRACTNot identified
ARTICHOKE POWDERARTICHOKE POWDERNot identified
ROYAL JELLYROYAL JELLYGelée royale
BEE POLLENBEE POLLENNot identified
SAFFLOWER SEED OILSAFFLOWER SEED OILNot identified
WHEAT GERM OILWHEAT GERM OILHuile de germes de blé
RIBOFLAVINRIBOFLAVINVitamine B2 (riboflavine)
PYRIDOXINE HYDROCHLORIDEPYRIDOXINE HYDROCHLORIDEVitamine B6
CYANOCOBALAMINCYANOCOBALAMINVitamine B12
GELATINGELATINNot identified
WATERWATERNot identified
GLYCEROLGLYCEROLGlycérol
BEESWAXBEESWAXNot identified
TITANIUM DIOXIDETITANIUM DIOXIDENot identified
SUNSET YELLOW FCFSUNSET YELLOW FCFNot identified
ALLURA RED ACALLURA RED ACNot identified
BRILLIANT BLUE FCFBRILLIANT BLUE FCFNot identified
SORBIC ACIDSORBIC ACIDNot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
1139038075
Chinese name
千維健膠囊食品
English name
COMBETASI SOFTGEL CAPSULES
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
雄美有限公司
Registration date
2024-06-18
Published validity end
2029-06-18

Original register data

View published fields and their variants
Product name
千維健膠囊食品
Active ingredients
CAYENNE FRUIT;;DESICCATED LIVER POWDER;;SOYBEAN EXTRACT;;DL-ALPHA TOCOPHERYL ACETATE;;PHYLLANTHUS URINARIA L. EXTRACT;;ARTICHOKE POWDER;;ROYAL JELLY;;BEE POLLEN;;SAFFLOWER SEED OIL;;WHEAT GERM OIL;;RIBOFLAVIN;;PYRIDOXINE HYDROCHLORIDE;;CYANOCOBALAMIN;;GELATIN;;WATER;;GLYCEROL;;BEESWAX;;TITANIUM DIOXIDE;;SUNSET YELLOW FCF;;ALLURA RED AC;;BRILLIANT BLUE FCF;;SORBIC ACID;;
Valid until
1180618
Registration number
1139038075
Licence holder
雄美有限公司
Registration date
1130618
Published reference
DHC0B390380751
Published English name
COMBETASI SOFTGEL CAPSULES

Official source

View the official register, number 1139038075

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • ROYAL JELLY
    Read the warning, when it applies and the studies cited

    ROYAL JELLY

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Contraindications

    Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).

    Sources cited by Health Canada (8)
    • Bullock RJ. Fatal royal-jelly induced asthma. Medical Journal of Australia 1994;160:44. PubMed Case report
    • Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report
    • Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
    • Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
    • Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
    • Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
    • TGA 2001: Australian Therapeutic Goods Administration. CMEC 28: Complementary Medicines Evaluation Committee, Extracted Ratified Minutes twenty-eight Meeting, 27-28 July 2001. Australian Government Department of Health and Aging, Sydney, Australia; 2001. [Accessed 2025 February 5]. Available from: https://www.tga.gov.au/sites/default/files/cmec-minutes-28.pdf
    • Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).

    Sources cited by Health Canada (6)
    • Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
    • Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
    • Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
    • Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
    • Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
    • Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report

    Health Canada monograph dated 24 April 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line